Skip to content Skip to footer

(RSV) Respiratory Syncytial Virus Clinical Trial

One Step Closer to Stronger Protection Against RSV

A Chance for Healthy People to Volunteer in RSV Research

Participate in Respiratory Syncytial Virus Vaccine Clinical Trials in Michigan!

Respiratory Syncytial Virus (RSV) is a common respiratory infection that can lead to serious complications, particularly in older adults and individuals with underlying health conditions. It can cause symptoms such as persistent cough, wheezing, and difficulty breathing, often making everyday activities more challenging.

Revival Research Institute is conducting a clinical trial to evaluate a potential new vaccine for RSV in older, healthy individuals. If you or someone you know is in good health and interested in contributing to the advancement of RSV prevention, you may be eligible to participate.

Are You Eligible to Participate?

To be eligible for our RSV Vaccine Clinical Trials, individuals must meet the following criteria:

*Additional criteria may apply.

*Take part in RSV Clinical Trials at no cost to you or your medical insurance. You will be reimbursed financially for your time and travel. In addition, all participants receive study-related care from an experienced research team.

*If you are interested in participating in the Respiratory Syncytial Virus Vaccine Clinical Trials in Michigan or would like more information, please fill out the form below so we can determine if you qualify for the study and contact you. Note that this is an entirely voluntary decision.

This field is for validation purposes and should be left unchanged.
Who is this information for?*(Required)

Please provide YOUR contact information only.

Name(Required)
Best Time to Call(Required)
User Agreement(Required)
This is our Privacy Policy.

About Respiratory Syncytial Virus Vaccine Trials Flyer

About Respiratory Syncytial Virus Vaccine Trials in Southfield, Michigan

Respiratory Syncytial Virus (RSV) is a common respiratory virus that can lead to serious complications, especially in older adults and individuals with weakened immune systems. Each year, RSV causes thousands of hospitalizations across the U.S., particularly during peak seasonal outbreaks.

As symptoms like persistent coughing, wheezing, or shortness of breath worsen, everyday activities such as walking, sleeping, or even talking can become difficult. The impact of RSV extends beyond physical symptoms. For older adults, RSV-related illness can disrupt routines, reduce independence, and contribute to prolonged recovery periods that affect overall well-being and quality of life.

Respiratory Syncytial Virus Vaccine Clinical Trials will be conducted in several locations across the United States, including Michigan. To ensure study eligibility, all participants must comply with study procedures.

*There is no cost to you, your private medical insurance, or the public health insurance plan for study procedures. The study-related procedures and visits will be provided at no charge throughout the duration of the study.

Get Started
What to Expect?

If you are interested and want to participate in a paid Respiratory Syncytial Virus Vaccine Clinical Trial, please reach out to us by filling out the form above. A member of our study team will contact you to begin the pre-screening process and determine if you may be eligible to participate.

If you qualify during this initial step, you’ll be invited for a screening visit at our clinical site. During this visit, our team will ask you a series of health-related questions and perform a few medical tests to confirm your eligibility. Once your eligibility is confirmed, you will officially become a participant in the RSV Vaccine Clinical Trial. You will receive detailed information about the study, including its purpose, procedures, and what to expect throughout your involvement. We encourage you to ask any questions you may have — your understanding and comfort are important to us.

Your safety is our top priority. Before joining the trial, you will be provided with all the necessary details about participation, including any potential benefits and risks. Throughout the study, your health will be closely monitored by our clinical team to ensure your well-being.

*All study-related care is provided free of cost. Complete physical examination and other study-related assessments will be done by expert physicians.

Age Icon
Age
60 years or older
Condition Icon
Condition
Respiratory Syncytial Virus (RSV)
Location Icon
Location
Michigan

About Respiratory Syncytial Virus (RSV) & Its Symptoms

Respiratory Syncytial Virus (RSV) is a common and highly contagious virus that affects the lungs and breathing passages. While RSV can resemble a mild cold in healthy individuals, it can lead to severe illness in infants, older adults, and people with weakened immune systems.

RSV May Be Influenced By

Respiratory Syncytial Virus (RSV) is caused by a virus that infects the respiratory tract. It spreads easily from person to person through:

While RSV is most common during the fall and winter, it can occur year-round and often causes seasonal outbreaks.

Common Symptoms of RSV Include

Symptoms can vary depending on age and overall health, but may include:

In vulnerable populations, RSV can progress to serious conditions like bronchiolitis or pneumonia, often requiring hospitalization. Because early symptoms can mimic those of a common cold, RSV may go unrecognized until it becomes more severe.

Frequently Asked Questions

Your Guide to Common Questions

We have answered some of the most asked questions about RSV, its symptoms, triggers, and everyday management, to help you feel more informed and supported. Are you looking for more guidance? Reach out to our amazing team: +1 (248) 721-9539

Yes, Respiratory Syncytial Virus Vaccine Clinical Trials are enrolling adults aged 60 years and older who are in good general health.

If eligible, you’ll be invited to visit our clinical research site where all study-related procedures, including vaccination, will take place.

Participants will receive a single dose of the investigational RSV vaccine. This is an open-label study in the U.S., which means all participants will receive the same vaccine formulation.

By participating, you may:

  • Receive expert medical care throughout the trial
  • Help advance vaccine research for RSV prevention in older adults
  • Gain early access to an investigational respiratory syncytial virus clinical trial
  • Be eligible for compensation for your time and travel

Yes, your safety is our top priority. The investigational respiratory syncytial virus vaccine has undergone earlier phases of testing. Throughout the study, our medical team will monitor your health closely, track any symptoms, and provide support. You will also be guided by informed consent and made aware of all potential risks and benefits before participating.